Phospho-DAXX (S668) Antibody

What is Phospho-DAXX (S668) Antibody and what does it detect?

Phospho-DAXX (S668) Antibody specifically recognizes DAXX protein only when phosphorylated at the Serine 668 residue. This antibody binds to the phosphorylation sequence LPsPP (where lowercase 's' represents the phosphorylated serine) . It does not detect non-phosphorylated DAXX or DAXX phosphorylated at different sites, making it a valuable tool for studying specific phosphorylation events in cellular signaling pathways .

What are the common applications for Phospho-DAXX (S668) Antibody?

Phospho-DAXX (S668) Antibody can be used in multiple experimental techniques:

The optimal dilutions should be determined by the end user for specific experimental conditions .

What is the molecular weight of phosphorylated DAXX protein?

The calculated molecular weight of DAXX is approximately 81 kDa, but the observed molecular weight in SDS-PAGE can range between 82-110 kDa . This variation may be due to post-translational modifications, including phosphorylation, which can affect protein migration during electrophoresis. When using Western blot, researchers should expect to see a band in this molecular weight range .

How should I validate the specificity of Phospho-DAXX (S668) Antibody in my experiments?

To validate antibody specificity, implement these methodological approaches:

• Phosphatase treatment: Treat one sample with lambda phosphatase to remove phosphate groups, which should eliminate signal from phospho-specific antibodies.

• Blocking peptide competition: Pre-incubate the antibody with the phosphorylated peptide immunogen, which should abolish specific binding as demonstrated in validation images .

• Phospho-ELISA: Compare binding to phosphorylated versus non-phosphorylated peptides. A proper phospho-specific antibody will show significantly stronger binding to the phosphorylated form .

• siRNA knockdown: Reduce DAXX expression using siRNA and observe decreased signal intensity in both total and phospho-specific antibody detection .

What are the optimal fixation methods for immunofluorescence when using Phospho-DAXX (S668) Antibody?

For immunofluorescence detection of phosphorylated DAXX:

• For adherent cells, use 4% formaldehyde in PBS for fixation.

• For suspension cells, use 8% formaldehyde in PBS .

It's crucial to quench endogenous peroxidase activity after fixation using the appropriate quenching buffer to reduce background signals. Follow fixation with proper permeabilization (typically 0.1% Triton X-100) to allow antibody access to nuclear DAXX, as DAXX is primarily located in the nucleus, PML bodies, and nucleolus .

How can I perform quantitative analysis of DAXX phosphorylation levels in cell-based assays?

Cell-based colorimetric ELISA provides an efficient method for quantitative analysis of DAXX phosphorylation:

• Seed cells in 96-well plates and treat with appropriate stimuli.

• Fix cells with formaldehyde and permeabilize.

• Block non-specific binding sites.

• Incubate with Phospho-DAXX (S668) primary antibody.

• Detect using HRP-conjugated secondary antibody.

• Measure colorimetric signal with a standard ELISA plate reader.

• Normalize data using crystal violet staining for cell number counts.

This method is advantageous for high-throughput screening and uses significantly less sample compared to traditional Western blotting .

How does phosphorylation at S668 affect DAXX subcellular localization and function?

DAXX demonstrates complex subcellular localization patterns that are influenced by its phosphorylation status. When phosphorylated at S668, DAXX may show altered distribution between the following compartments:

• Nucleus, nucleoplasm

• PML nuclear bodies

• Nucleolus

• Chromosome centromeres

• Cytoplasmic punctate structures

DAXX colocalizes with histone H3.3, ATRX, HIRA, and ASF1A at PML nuclear bodies, which is important for its function in chromatin remodeling . Phosphorylation at S668 may regulate these interactions and subsequently affect DAXX's roles in transcriptional regulation and apoptotic signaling.

What are the technical considerations for detecting phospho-DAXX in phosphoproteomic studies?

When incorporating phospho-DAXX detection in phosphoproteomic studies:

• Enrichment strategy: Use TiO₂-based enrichment for phosphopeptides before mass spectrometry analysis .

• Internal standards: Consider using heavy-labeled phospho-spiketides as internal standards for accurate quantification as implemented in pHASED (Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA) approaches .

• Mass spectrometry settings: For optimal detection of DAXX phosphopeptides, use multiple compensation voltages (CV; −70, −60, −50, −40) with FAIMS interface to increase phosphoproteome coverage .

• Data analysis: Apply Kinase-Substrate Enrichment Analysis (KSEA) to determine kinase activity based on substrate phosphorylation levels .

• Statistical thresholds: Consider phosphopeptides with log₂ fold change ≥ 0.5 or ≤ −0.5 with p ≤ 0.05 as significantly differentially expressed .

How can I detect multiple phosphorylation sites on DAXX simultaneously?

To detect multiple phosphorylation sites on DAXX simultaneously:

• Multiplexed immunoassays: Use a combination of antibodies targeting different phosphorylation sites with distinct fluorescent or chromogenic labels.

• Mass spectrometry approach: Employ LC-MS/MS combined with phosphopeptide enrichment strategies. The pHASED approach identified significantly more singly (1066), doubly (463), and triply (71.67) phosphorylated peptides compared to standard LFQ methods .

• Phospho-proteomic arrays: Consider custom phospho-arrays with antibodies against multiple DAXX phosphorylation sites for high-throughput screening.

• Sequential immunoprecipitation: Perform serial immunoprecipitations with different phospho-specific antibodies to isolate distinct phosphorylated forms of DAXX.

What are common issues in Western blot detection of phospho-DAXX (S668) and how can they be resolved?

For optimal results, ensure extraction buffers contain both protease and phosphatase inhibitors, and maintain samples at 4°C throughout processing .

How should I interpret changes in DAXX S668 phosphorylation in relation to cellular signaling pathways?

When analyzing DAXX S668 phosphorylation data:

• Pathway context: DAXX is involved in apoptosis pathways through interaction with Fas death domain. Phosphorylation at S668 may modulate this interaction and its downstream effects on the JNK pathway activation .

• Kinase identification: Use Kinase-Substrate Enrichment Analysis (KSEA) or Ingenuity Pathway Analysis (IPA) to predict upstream kinases responsible for S668 phosphorylation .

• Temporal dynamics: Consider the timing of phosphorylation events in relation to cell death signals or other cellular stresses.

• Correlation with function: Correlate phosphorylation status with known DAXX functions, such as histone chaperoning, transcriptional repression, or apoptosis induction .

• Interaction network: Analyze how S668 phosphorylation affects DAXX interactions with binding partners through co-immunoprecipitation experiments.

What considerations should be made when comparing phospho-DAXX detection across different cell types or tissues?

When comparing phospho-DAXX across different experimental systems:

• Basal phosphorylation levels: Different cell types may exhibit varying baseline levels of DAXX S668 phosphorylation.

• Protein expression: Normalize phospho-DAXX signal to total DAXX protein levels, which may vary across tissues.

• Phosphatase activity: Consider inherent differences in phosphatase activity between tissues that might affect detection.

• Fixation sensitivity: Tissue-specific fixation requirements may affect epitope availability; optimize protocols for each tissue type.

• Signal transduction differences: Cell type-specific signaling networks may result in different functional outcomes from the same phosphorylation event.

• Antibody validation: Re-validate antibody specificity in each new cell type or tissue using the methods described in question 2.1 .

How can phospho-DAXX (S668) detection be integrated into cancer research and potential therapeutic development?

Phospho-DAXX (S668) detection offers several promising avenues for cancer research:

• Biomarker development: Evaluate whether S668 phosphorylation status correlates with cancer progression or therapeutic response.

• Drug screening: Use cell-based phospho-DAXX ELISA to screen compounds that modulate DAXX phosphorylation as potential therapeutic agents .

• Resistance mechanisms: Investigate whether altered DAXX phosphorylation contributes to treatment resistance in cancer cells.

• Combination therapies: Explore how modulating DAXX phosphorylation might sensitize cancer cells to existing therapies.

• Real-time phosphoproteomics: Implement methods like pHASED for rapid phosphoproteomic profiling to aid in cancer drug selection .

What emerging technologies could improve the sensitivity and specificity of phospho-DAXX detection?

Several cutting-edge approaches could enhance phospho-DAXX detection:

• Single-cell phosphoproteomics: Adapt techniques to detect phospho-DAXX at the single-cell level to understand cellular heterogeneity.

• Proximity ligation assays: Implement in situ detection of phosphorylated DAXX and its interaction partners with spatial resolution.

• CRISPR-based reporters: Develop knock-in fluorescent reporters that indicate DAXX phosphorylation status in live cells.

• Nanobody-based detection: Design nanobodies with higher specificity for phospho-epitopes.

• FAIMS-enhanced mass spectrometry: Further optimize FAIMS parameters for enhanced detection of DAXX phosphopeptides in complex samples .

• Heavy-labeled internal standards: Implement isotope-labeled peptide standards for absolute quantification of phospho-DAXX levels .